PIC
NVS icon

Portland Investment Counsel’s Novartis NVS Stock Holding History

Portland Investment Counsel’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		$483K Hold
7,035
– – 1.36% 16
2013
Q2 		$446K Buy
+7,035
New +$458K 1.33% 16

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BTS
BB&T Securities Richmond, Virginia $10.9B AUM 16.21% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
MAA
Managed Account Advisors Jersey City, New Jersey $121B AUM 7.42% 1-Year Est. Return

Portland Investment Counsel's NVS Position: Q3 2013 in Review

Portland Investment Counsel held its Novartis (NVS) position steady in Q3 2013 at 7,035 shares worth $483K. The position accounts for 1.36% of the portfolio, ranked #16.

Portland Investment Counsel first reported a position in NVS in Q2 2013 and has held it in 2 quarters since. 761 funds tracked by Wall St. Rank hold NVS as of Q3 2013.

  • Portland Investment Counsel held 7,035 shares of Novartis worth $483K as of Q3 2013.
  • Portland Investment Counsel left its Novartis share count unchanged in Q3 2013.
  • Novartis made up 1.36% of Portland Investment Counsel's portfolio in Q3 2013, its #16 holding.
  • Portland Investment Counsel first reported a position in Novartis in Q2 2013 and has held it in 2 quarters since.
  • 761 funds tracked by Wall St. Rank held Novartis as of Q3 2013.

Based on Portland Investment Counsel's 13F filing for Q3 2013, filed 13 Nov 2013.